Biostage, Inc.
BSTG · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $112 | $302 | $33 | $257 |
| Gross Profit | -$112 | -$302 | -$33 | -$257 |
| % Margin | – | – | – | – |
| R&D Expenses | $655 | $697 | $601 | $104 |
| G&A Expenses | $1,045 | $1,151 | $1,071 | $1,078 |
| SG&A Expenses | $1,070 | $1,151 | $1,081 | $801 |
| Sales & Mktg Exp. | $25 | $0 | $10 | $99 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,725 | $1,848 | $1,682 | $905 |
| Operating Income | -$1,837 | -$2,150 | -$1,715 | -$1,623 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $137 | $327 | $56 | $279 |
| Pre-Tax Income | -$1,700 | -$1,823 | -$1,659 | -$1,344 |
| Tax Expense | $0 | $0 | $0 | -$3 |
| Net Income | -$1,700 | -$1,823 | -$1,659 | -$1,344 |
| % Margin | – | – | – | – |
| EPS | -0.1 | -0.11 | -0.1 | -0.07 |
| % Growth | 9.1% | -10% | -42.9% | – |
| EPS Diluted | -0.1 | -0.11 | -0.1 | -0.07 |
| Weighted Avg Shares Out | 17,033 | 15,919 | 15,919 | 14,789 |
| Weighted Avg Shares Out Dil | 17,033 | 15,919 | 15,919 | 14,789 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $7 | $13 | $32 |
| Interest Expense | $2 | $3 | $2 | -$41 |
| Depreciation & Amortization | $25 | $0 | $0 | $17 |
| EBITDA | -$1,673 | -$2,150 | -$1,715 | -$637 |
| % Margin | – | – | – | – |